The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context..

Highlights

• Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities
• Examines next-generatione monitor technologies, design issues and evolving market factors
• Provides forecasts and market data for self-monitoring products to 2015
• Assesses the impact and influence of self-monitoring enhancements on the healthcare management market
• Profiles self-monitoring market participants, their technology, product development activity, and business strategies

Table Of Contents

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview
Key Factors in Patient Compliance
Market Drivers
Shifting Patient Demographics
Industry Alignment and Competitive Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests
Dry Chemistry Test Strips
Cassettes
Meters
Self-Collected / Mail-in Tests
Combination Meters
Continuous Monitors
Future Developments
Noninvasive Monitors
Technologies
Optical
Energy-based
Thermal
Signal Processing Advances

Monitor Product Design and Patient Issues

Reliability
Measurement Frequency
Patient/User Interface
Ease-of-Use
Data Collection/Data Display
Continuous vs Discrete Monitoring
Measurement Electronics
Calibration
Accuracy/Precision
Sensitivity
Sensor Technology

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)
Total Cholesterol
Triclycerides
Cholesterol Panel/Lipid Profile
Diabetes (Glucose)
OTC Meters
Alternate Site Testing
Continuous Monitoring
Heart Valve Replacement/Thrombosis
Oral Anticoagulation Therapy
Prothrombin Time
Hypertension (Blood Pressure)
Oscillometric Measurements
Demographic Trends

Self-Monitoring Product Segment Analysis

Cholesterol Monitors
FDA Approved Products
Products in Development
Coagulation Monitoring
FDA Approved Products
Products in Development
Glucose Monitors
Traditional Meters
Needle-stick
Alternate Site Testing
Continuous Monitors
FDA-Approved Monitors
Development-stage Monitors
Noninvasive Glucose Monitors
Combination Monitors
Product Design Factors
FDA Approved Products
Hypertension
Existing Products
Emerging Technologies
Potential/Emerging Self-Monitoring Segments

Market Factors

Clinical Trial Issues
Regulations and Guidance
Managed care/Reimbursement
Patient Compliance
Marketing and Distribution
Sourcing/Private Labeling

Patient Self-Monitoring - Company Profile

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.